IP Library Granted Patent US 9,631,025
Granted Patent B2
US 9,631,025 · App. 14/825,661 · Granted Apr 25, 2017

Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies

Inventors: Cynthia A. Vistica (Dublin, CA); Eric H. Holmes (Bothell, WA); Peter Brams (Sacramento, CA); Alison Witte (Rogue River, OR); Josephine M. Cardarelli (San Carlos, CA)
Assignee: E. R. SQUIBB & SONS, L.L.C.
C07K16/3084A61K39/39558A61K45/06A61K2039/505C07K2317/21C07K2317/56C07K2317/565C07K2317/732C07K2317/734C07K2317/77
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,631,025
App. No.
14/825,661
Granted
Apr 25, 2017
Kind
B2
Abstract

The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to Fucosyl-GM1 with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of this disclosure are also provided. This disclosure also provides methods for detecting Fucosyl-GM1, as well as methods for treating various diseases, including cancer, using anti-Fucosyl-GM1 antibodies.

Claims (28)

1. An isolated nucleic acid molecule encoding the heavy and/or light chain of a human monoclonal antibody, or antigen-binding portion thereof, that cross-competes for binding to Fucosyl-GM1 with a second antibody comprising:

(a) a heavy chain variable region comprising the amino acid sequence of SEQ ID NO:4; and

(b) a light chain variable region comprising the amino acid sequence of SEQ ID NO:10.

2. An expression vector comprising the nucleic acid of claim 1 .

3. A host cell comprising the expression vector of claim 2 .

4. A method for preparing an anti-Fucosyl-GM1 antibody comprising:

(a) expressing the antibody in the host cell of claim 3 ; and

(b) isolating the antibody from the host cell.

5. The isolated nucleic acid molecule of claim 1 encoding the heavy and/or light chain of a monoclonal antibody, or antigen-binding portion thereof, comprising:

(a) a heavy chain variable region CDR1 domain comprising SEQ ID NO:16;

(b) a heavy chain variable region CDR2 domain comprising SEQ ID NO:22;

(c) a heavy chain variable region CDR3 domain comprising SEQ ID NO:28;

(d) a light chain variable region CDR1 domain comprising SEQ ID NO:34;

(e) a light chain variable region CDR2 domain comprising SEQ ID NO:40; and

(f) a light chain variable region CDR3 domain comprising SEQ ID NO:46.

6. An expression vector comprising the nucleic acid molecule of claim 5 .

7. A host cell comprising the expression vector of claim 6 .

8. A method for preparing an anti-Fucosyl-GM1 antibody comprising:

(a) expressing the antibody in the host cell of claim 7 ; and

(b) isolating the antibody from the host cell.

9. The isolated nucleic acid molecule of claim 5 encoding the heavy and/or light chain of a monoclonal antibody, or antigen-binding portion thereof, comprising:

(a) a heavy chain variable region comprising the amino acid sequence of SEQ ID NO:4; and

(b) a light chain variable region comprising the amino acid sequence of SEQ ID NO:10.

10. An expression vector comprising the nucleic acid molecule of claim 9 .

11. A host cell comprising the expression vector of claim 10 .

12. A method for preparing an anti-Fucosyl-GM1 antibody comprising:

(a) expressing the antibody in the host cell of claim 11 ; and

(b) isolating the antibody from the host cell.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2016
From: VISTICA, CYNTHIA A.; HOLMES, ERIC H.; BRAMS, PETER; WITTE, ALISON; CARDARELLI, JOSEPHINE M.
To: MEDAREX, INC.
Reel/Frame 037663/0571 →
MERGER Recorded Feb 4, 2016
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 037663/0702 →
MERGER Recorded Feb 4, 2016
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 037664/0253 →
Continuity (4)
Division 13746762 · Jan 22, 2013
Division 12095557
Provisional Application 60748915 · Dec 8, 2005
Related Publication 20160024221A1 · Jan 28, 2016